Eidos Therapeutics initiated at Leerink
Eidos Therapeutics initiated with an Outperform at Leerink. Leerink analyst Mani Foroohar initiated Eidos Therapeutics with an Outperform rating and a price target of $32.https://thefly.com/landingPageNews.php?id=2828743
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.